Publications > Journals > Future Integrative Medicine > Special Feature

Time: May 13, 2022


Journal: Future Integrative Medicine

Special Issue: Therapeutic strategies involving herbal medicines and bioactive ingredients for viral infections and secondary critical illness: interventions for inflammatory response and organ protection

Keywords: Herbal medicine; Viral infections; Critical illness; Inflammatory response; Organ protection

Guest Editor-in-Chief: Prof. Qingquan Liu

Co-Guest Editors: Dr. Xiaolong Xu, Dr. Shasha He, Dr. Xuerui Wang

Status: Open

Submission deadlines:

Abstract Submission: June 1, 2022

Manuscript Submission: December 31, 2022

Publication date: An article will be published online as soon as it is accepted.


Guest Editor-in-Chief's Profile:


Image

Qingquan Liu
Professor, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University 

Prof. Liu holds a Bachelor's degree from Henan College of Traditional Chinese Medicine (1982–1987) and has expertise in studying the use of traditional Chinses herbal medicines for treatment of intensive care diseases. His work also covers the pathogenesis of sepsis, psoriasis, and inflammatory diseases. He is continuing his research in the Beijing Hospital of Traditional Chinese Medicine, Beijing Institute of Traditional Chinese Medicine, and Beijing Key Laboratory of Basic Research with Traditional Chinese Medicine on Infectious Diseases. As first or corresponding author, he has published several papers in journals including the Annals of Internal Medicine, Engineering, Frontiers in Immunology, Free Radical Biology and Medicine, Oxidative Medicine and Cellular Longevity, Frontiers in Pharmacology, and others. 

Co-Guest Editors’ Profiles:


Image

Xiaolong Xu
Associate Professor, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University 

Dr. Xu received a PhD from China Agriculture University (20122015) and has expertise in studying traditional Chinese herbal medicines with anti-inflammatory properties. His research also covers the pathogenesis of sepsis, psoriasis, and infectious diseases. He is continuing his research in Beijing Hospital of Traditional Chinese Medicine, Beijing Institute of Chinese Medicine, and Beijing Key Laboratory of Basic Research with Traditional Chinese Medicine on Infectious Diseases. As first or corresponding author, he has published several papers in journals including Frontiers in Immunology, Free Radical Biology and Medicine, Oxidative Medicine and Cellular Longevity, Frontiers in Pharmacology, and others. 

Image

Shasha He
Associate Researcher, Beijing Institute of Chinese Medicine 

Dr. He's research interests include the pharmacological mechanisms of traditional Chinese medicine (TCM) compounds and their main active substances in the prevention and treatment of organ injury in infectious diseases. Her related research provides a theoretical basis for the treatment of sepsis with TCM and contributes to the research and development of new drugs. As first or corresponding author, she has published several papers in authoritative journals in related fields such as Oxidative Medicine and Cellular Longevity, Frontiers in Pharmacology, International Journal of Hyperthermia, Molecular Biosystems, and others. 

Image

Xuerui Wang
Research Assistant, Beijing Institute of Chinese Medicine 

Dr. Wang is currently working in the Beijing Institute of Chinese Medicine. Her research interests are the clinical efficacy and mechanisms of traditional Chinese medicine for the prevention and treatment of infectious diseases, such as sepsis and viral pneumonia. She is currently the academic editor of Evidence-based Complementary and Alternative Medicine. As first author, she has published several papers in journals including Hypertension, Free Radical Biology and Medicine, Frontiers in Pharmacology, and others. 

Viral infections, including SARS CoV-2, influenza virus, and other viruses, poses a serious threat to global public health and safety. Secondary critical illness caused by viral infections is a major cause of death among patients receiving intensive care. Herbal medicines have been proven effective for treating viral infections and critical illness. However, high-level evidence and in-depth mechanistic research are still lacking, limiting the clinical application of such medicines.

This issue welcomes basic and translational studies evaluating the clinical effectiveness, underlying mechanisms, and integrative pharmacology of herbal medicines and bioactive ingredients for treatment of viral infections. The studies may include, but are not limited to, humans and animal models.

Authors should refer to the Instructions for Authors in preparing  the manuscript and kindly submit it through the Online Submission System directly.

 

Priority will be given with the same high standards of peer review and publication process for these articles. All publications will open free access to all readers. We guarantee that all accepted papers related to immunoregulatory mechanisms of herbal medicines in cancer and infectious diseases will be highlighted in a special section on our website.

 

Online submission system: https://www.publinexh.com/ 

Article processing charge: None

Instructions for authors: Please state in a cover letter that the manuscript is being submitted for inclusion in the special issue 'Therapeutic strategies involving herbal medicines and bioactive ingredients for viral infections and secondary critical illness: interventions for inflammatory response and organ protection', and follow the usual FIM instructions. Please refer to: https://www.xiahepublishing.com/journal/fim/instruction

For any inquiries, please contact the journal by e-mail: [email protected]